Completed
Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants
NCT05641311
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +16 more
- Locations
-
- Richmond Pharmacology Ltd., St George's University of London London, United Kingdom